Brilinta (Ticagrelor) for Heart Disease

Overview
Brilinta is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of stroke, myocardial infarction (MI or heart attack), or cardiovascular death in people who have acute coronary syndrome or a history of MI. Brilinta may also be prescribed to reduce the risk of blood clots in people who have received stents. Brilinta may also be referred to by its drug name, Ticagrelor.

Brilinta is an anticoagulant, or blood thinner. It is believed that Brilinta works by inhibiting platelets from forming clots.

How do I take it?
Brilinta is generally taken twice daily.

Brilinta comes in tablet form.

Side effects
The FDA-approved label for Brilinta lists common side effects including trouble breathing and abnormal bleeding.

Rare but serious side effects listed for Brilinta include increased risk for severe liver impairment.

For more details about this treatment, visit:

Brilinta.com – AstraZeneca
https://www.brilinta.com/